Gene · 64324
Papers2,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive profiling of circRNAs reveals stimulus-specific networks and core regulators of cellular senescence. | PLoS One | 2026 | 41758785 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Congenital hyperinsulinism in an individual with CHARGE syndrome and a pathogenic CHD7 variant. | JCEM Case Rep | 2026 | 41743177 | PubTator, text mining | PubMed |
| Structure and validity of the Subjective Traumatic Outlook questionnaire under conditions of continuous trauma. | BJPsych Open | 2026 | 41725309 | PubTator, text mining | PubMed |
| ALDH2 inhibits head and neck tumorigenesis through RAS signaling suppression, transactivation of TGM2, and synergy with ALDH6A1. | Cell Mol Life Sci | 2026 | 41721860 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazole: A Privileged Scaffold for Tyrosine Kinase-Targeted Anticancer Agents. | Zhongguo Ying Yong Sheng Li Xue Za Zhi | 2026 | 41645354 | PubTator, text mining | PubMed |
| SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study. | PLoS One | 2026 | 41642899 | PubTator, text mining | PubMed |
| DNA methylation landscapes in human cells and their chromatin determinants. | Ageing Cancer Res Treat | 2026 | 41641439 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics uncover neoadjuvant chemotherapy-resistant malignant cells with inhibitory signalling on B cells in gastric cancer. | Clin Transl Med | 2026 | 41630531 | PubTator, text mining | PubMed |
| Targeting epithelial-mesenchymal transition and apoptosis: novel histone methyltransferase inhibitors for colon cancer suppression. | Bioorg Med Chem | 2026 | 41576672 | PubTator, text mining | PubMed |
| The GF-NEO discovery platform unveils a [KQE][DG] sequence motif within fusion neoantigens in pediatric cancer. | iScience | 2026 | 41567246 | PubTator, text mining | PubMed |
| PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype. | Ann Hematol | 2026 | 41566085 | PubTator, text mining | PubMed |
| The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1. | Oncogenesis | 2026 | 41554700 | PubTator, text mining | PubMed |
| Unraveling lipedema: comprehensive insights and the path to future discoveries. | NPJ Metab Health Dis | 2026 | 41548036 | PubTator, text mining | PubMed |
| Many faces of mammalian NSD methyltransferases. | Cell Mol Biol Lett | 2026 | 41495645 | PubTator, text mining | PubMed |
| Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up. | Clin Endocrinol (Oxf) | 2026 | 41473979 | PubTator, text mining | PubMed |
| Prenatal Diagnosis of Sotos Syndrome: Integrating Chromosomal Microarray Analysis and Exome Sequencing. | Prenat Diagn | 2026 | 41260619 | PubTator, text mining | PubMed |
Discovery metabolomics and genetic analysis reveal lipid pathway alterations associated with malignant phenotype acquisition in pleomorphic adenoma and a novel NTF3::ITPR2 fusion in carcinoma ex pleomorphic adenoma. | Virchows Arch | 2026 | 41081890 | PubTator, text mining | PubMed |
| Hyperinsulinemia in Sotos Syndrome with a de novo NSD1 Deletion | J Clin Res Pediatr Endocrinol | 2026 | 38344969 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64324/papers?page=2